ホーム › 非小細胞肺癌 › ワシントン › Spokane Valley
Spokane Valley、WAにおける非小細胞肺癌の臨床試験
Spokane Valleyとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
被験者募集中第3相
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14マイル先
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21マイル先
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14マイル先
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21マイル先
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
被験者募集中第3相
- Beacon Cancer Care ( Site 0127), Post Falls · 14マイル先
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
被験者募集中第3相
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14マイル先
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21マイル先
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
被験者募集中第2相
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14マイル先
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21マイル先
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
被験者募集中第3相
- Cancer Care Northwest - Vercler, Spokane Valley
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
被験者募集中第3相
- Local Institution - 0509, Coeur d'Alene · 21マイル先
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
被験者募集中観察研究
- Kootenai Clinic Cancer Services Coeur d'Alene, Coeur d'Alene · 21マイル先
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
被験者募集中第2相
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14マイル先
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14マイル先
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21マイル先
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2/3相
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14マイル先
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21マイル先
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14マイル先
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21マイル先
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14マイル先
- Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21マイル先
GEMINI-NSCLC: NSCLC Biomarker Study
被験者募集中観察研究
- Cancer Care Northwest, Spokane Valley
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
Spokane Valleyにおける他の研究
- 前立腺がん9件の研究
- 乳がん8件の研究
- 肺がん8件の研究
- 急性骨髄性白血病7件の研究
- 悪性黒色腫6件の研究
- 転移性癌4件の研究
- がん（全種類）4件の研究
- 膀胱癌4件の研究
- 頭頸部扁平上皮癌4件の研究
- 結腸癌4件の研究
- 大腸癌4件の研究
- 子宮内膜がん3件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。